INVITROGEN CORP IVGN (NASDAQ)

(WASHINGTON)The Food and Drug Administration on Tuesday approved a new genetic test from Invitrogen Corp. which identifies breast cancer patients who will respond to a powerful cancer-fighting...READ MORE

(NEW YORK)Analysts say there may be more consolidation in the life sciences sector following Invitrogen Corp.'s purchase of Applied Biosystems Group and Thermo Fisher's acquisition o...READ MORE

(WASHINGTON)Invitrogen Corp. spent $160,000 in the first quarter to lobby on funding for biomedical research, the National Institutes of Health and more, according to a recent disclosure form....READ MORE

(NEW YORK)Shares of Illumina Inc. and Edwards Lifesciences hit new 52-week highs Wednesday, as a Cowen & Co. analyst said a potential increase in the National Institute of Health's fisca...READ MORE

Among the premarket stories for Tuesday, June 24, from AP Financial News: NEW YORK (AP)--A Credit Suisse analyst started coverage of the homebuilder sector with an "Overweight" rat...READ MORE

(NEW YORK)A JPMorgan analyst upgraded shares of Invitrogen Corp. Tuesday, pointing to greater-than-expected possible savings in the company's acquisition of Applied Biosystems, and to de...READ MORE

(NEW YORK)Life sciences equipment maker Invitrogen Inc. said Friday its head of global operations, Mark Smedley, will lead an integration team through the $6.4 billion buyout of Applied Bios...READ MORE